fiona mcdonald
fiona mcdonald
Verified email at
Cited by
Cited by
Clinical development of new drug–radiotherapy combinations
RA Sharma, R Plummer, JK Stock, TA Greenhalgh, O Ataman, S Kelly, ...
Nature reviews Clinical oncology 13 (10), 627-642, 2016
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
M Guckenberger, C Belka, A Bezjak, J Bradley, ME Daly, D DeRuysscher, ...
Radiotherapy and Oncology 146, 223-229, 2020
UK consensus on normal tissue dose constraints for stereotactic radiotherapy
GG Hanna, L Murray, R Patel, S Jain, KL Aitken, KN Franks, N Van As, ...
Clinical Oncology 30 (1), 5-14, 2018
Definition of synchronous oligometastatic non–small cell lung cancer—a consensus report
AMC Dingemans, LEL Hendriks, T Berghmans, A Levy, B Hasan, ...
Journal of thoracic oncology 14 (12), 2109-2119, 2019
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer
U Nestle, D De Ruysscher, U Ricardi, X Geets, J Belderbos, C Pöttgen, ...
Radiotherapy and oncology 127 (1), 1-5, 2018
Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a …
AO Clive, H Taylor, L Dobson, P Wilson, E de Winton, N Panakis, ...
The Lancet Oncology 17 (8), 1094-1104, 2016
Lung stereotactic body radiotherapy with an MR-linac–Quantifying the impact of the magnetic field and real-time tumor tracking
MJ Menten, MF Fast, S Nill, CP Kamerling, F McDonald, U Oelfke
Radiotherapy and Oncology 119 (3), 461-466, 2016
Treatment characteristics and real-world progression-free survival in patients with unresectable stage III NSCLC who received durvalumab after chemoradiotherapy: findings from …
N Girard, J Bar, P Garrido, MC Garassino, F McDonald, F Mornex, ...
Journal of Thoracic Oncology 18 (2), 181-193, 2023
Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiation
F McDonald, S Lalondrelle, H Taylor, K Warren-Oseni, V Khoo, ...
Clinical Oncology 25 (9), 549-556, 2013
Management of stage I and II nonsmall cell lung cancer
F McDonald, M De Waele, LEL Hendriks, C Faivre-Finn, AMC Dingemans, ...
European Respiratory Journal 49 (1), 2017
The dandelion dilemma revisited for oligoprogression: treat the whole lawn or weed selectively?
PH Patel, D Palma, F McDonald, AC Tree
Clinical Oncology 31 (12), 824-833, 2019
Systemic treatment of brain metastases in non-small cell lung cancer
S Page, C Milner-Watts, M Perna, U Janzic, N Vidal, N Kaudeer, M Ahmed, ...
European Journal of Cancer 132, 187-198, 2020
Clinical outcomes of image guided adaptive hypofractionated weekly radiation therapy for bladder cancer in patients unsuitable for radical treatment
S Hafeez, F McDonald, S Lalondrelle, H McNair, K Warren-Oseni, ...
International Journal of Radiation Oncology* Biology* Physics 98 (1), 115-122, 2017
Magnetic resonance imaging in precision radiation therapy for lung cancer
H Bainbridge, A Salem, RHN Tijssen, M Dubec, A Wetscherek, C Van Es, ...
Translational lung cancer research 6 (6), 689, 2017
Treating locally advanced lung cancer with a 1.5 T MR-Linac–Effects of the magnetic field and irradiation geometry on conventionally fractionated and isotoxic dose-escalated …
HE Bainbridge, MJ Menten, MF Fast, S Nill, U Oelfke, F McDonald
Radiotherapy and oncology 125 (2), 280-285, 2017
Reduced fractionation in lung cancer patients treated with curative-intent radiotherapy during the COVID-19 pandemic
C Faivre-Finn, JD Fenwick, KN Franks, S Harrow, MQF Hatton, C Hiley, ...
Clinical Oncology 32 (8), 481-489, 2020
Prospective study delivering simultaneous integrated high-dose tumor boost (≤ 70 Gy) with image guided adaptive radiation therapy for radical treatment of localized muscle …
S Hafeez, K Warren-Oseni, HA McNair, VN Hansen, K Jones, M Tan, ...
International Journal of Radiation Oncology* Biology* Physics 94 (5), 1022-1030, 2016
Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy—a planning study
J Brock, J Bedford, M Partridge, F McDonald, S Ashley, HA McNair, ...
Clinical oncology 24 (1), 68-75, 2012
Practical management of oligometastatic non–small-cell lung cancer
K Jasper, B Stiles, F McDonald, DA Palma
Journal of Clinical Oncology 40 (6), 635-641, 2022
Targeting the PD-1/PD-L1 axis in non–small cell lung cancer
R Kumar, D Collins, S Dolly, F McDonald, MER O’Brien, TA Yap
Current problems in cancer 41 (2), 111-124, 2017
The system can't perform the operation now. Try again later.
Articles 1–20